Blinatumomab Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 35mcg

Reference Brands: Blincyto (USA/EU)

Category: Oncology Cancer Care

Blinatumomab is a bispecific T-cell engager (BiTE) antibody used in the treatment of B-cell precursor acute lymphoblastic leukemia (ALL). It works by connecting T-cells to cancerous B-cells, enabling the immune system to destroy them. Marketed under the brand name Blincyto, it is available as a powder for infusion (35 µg or 38.5 µg per vial). It is used in both adults and children with relapsed, refractory, or minimal residual disease–positive ALL. Blinatumomab is available in Injection and strengths such as 35mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Blinatumomab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Blinatumomab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.